- Pre-menopausal women aged 18-45 with a primary diagnosis of Female Sexual Arousal
Disorder for at least 6 months prior to entering the study. The FSAD could have been
associated with female orgasmic disorder (FOD) and/or superficial or introital
- Subjects with hypoactive sexual desire disorder.
- Subjects not using an acceptable mean of contraception for the duration of the study.
- Subjects who were prescribed and/or taking medication which were contraindicated or
cautioned with concomitant intake of sildenafil.